Cargando…
Multicenter randomized trial of cell therapy in cardiopathies – MiHeart Study
BACKGROUND: Cardiovascular diseases are the major cause of death in the world. Current treatments have not been able to reverse this scenario, creating the need for the development of new therapies. Cell therapies have emerged as an alternative for cardiac diseases of distinct causes in experimental...
Autores principales: | Tura, Bernardo R, Martino, Helena F, Gowdak, Luis H, dos Santos, Ricardo Ribeiro, Dohmann, Hans F, Krieger, José E, Feitosa, Gilson, Vilas-Boas, Fábio, Oliveira, Sérgio A, Silva, Suzana A, Bozza, Augusto Z, Borojevic, Radovan, de Carvalho, Antonio C Campos |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1783861/ https://www.ncbi.nlm.nih.gov/pubmed/17233910 http://dx.doi.org/10.1186/1745-6215-8-2 |
Ejemplares similares
-
Multicenter double blind trial of autologous bone marrow mononuclear cell transplantation through intracoronary injection post acute myocardium infarction – MiHeart/AMI study
por: Dohmann, Hans FR, et al.
Publicado: (2008) -
Atrial cardiopathy and stroke
por: Elkind, Mitchell S. V.
Publicado: (2022) -
Atrial Cardiopathy and Cryptogenic Stroke
por: Kato, Yuji, et al.
Publicado: (2022) -
Atrial cardiopathy and cognitive impairment
por: Myers, Sarah J., et al.
Publicado: (2022) -
Age-related cardiopathies gene editing
por: Song, Moshi, et al.
Publicado: (2019)